
Hal Ira Kaplan
Examiner (ID: 11029, Phone: (571)272-8587 , Office: P/2836 )
| Most Active Art Unit | 2836 |
| Art Unit(s) | 2836 |
| Total Applications | 1588 |
| Issued Applications | 1362 |
| Pending Applications | 72 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11627438
[patent_doc_number] => 20170137627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'COLOR CONVERSION IN LCD DISPLAYS'
[patent_app_type] => utility
[patent_app_number] => 15/353294
[patent_app_country] => US
[patent_app_date] => 2016-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 18741
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15353294
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/353294 | Red-enhanced white LCD displays comprising sol-gel-based color conversion films | Nov 15, 2016 | Issued |
Array
(
[id] => 12037621
[patent_doc_number] => 09815839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/351592
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83958
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351592 | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors | Nov 14, 2016 | Issued |
Array
(
[id] => 15977897
[patent_doc_number] => 10669256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/318055
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 48
[patent_no_of_words] => 12915
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318055 | Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereof | Nov 10, 2016 | Issued |
Array
(
[id] => 11497714
[patent_doc_number] => 20170071899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/347059
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19631
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347059
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347059 | Ultrapure tetrahydrocannabinol-11-oic acids | Nov 8, 2016 | Issued |
Array
(
[id] => 11497715
[patent_doc_number] => 20170071900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'ULTRAPURE TETRAHYDROCANNABINOL-11-OIC-ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/347104
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19632
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347104
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347104 | Ultrapure tetrahydrocannabinol-11-oic acids | Nov 8, 2016 | Issued |
Array
(
[id] => 13093243
[patent_doc_number] => 10065952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Valbenazine salts and polymorphs thereof
[patent_app_type] => utility
[patent_app_number] => 15/338214
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 29438
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15338214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/338214 | Valbenazine salts and polymorphs thereof | Oct 27, 2016 | Issued |
Array
(
[id] => 14294315
[patent_doc_number] => 10287272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Substituted indazole compounds as RORgammaT inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/770256
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 33707
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770256 | Substituted indazole compounds as RORgammaT inhibitors and uses thereof | Oct 26, 2016 | Issued |
Array
(
[id] => 11441835
[patent_doc_number] => 20170042856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHOD AND COMPOSITION FOR TREATING ACNE'
[patent_app_type] => utility
[patent_app_number] => 15/334987
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9069
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334987
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/334987 | METHOD AND COMPOSITION FOR TREATING ACNE | Oct 25, 2016 | Abandoned |
Array
(
[id] => 15054761
[patent_doc_number] => 10457669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Benzolactam compounds as protein kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/767775
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 164090
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1064
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767775 | Benzolactam compounds as protein kinase inhibitors | Oct 19, 2016 | Issued |
Array
(
[id] => 11419803
[patent_doc_number] => 20170027946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'SUBSTITUTED XANTHINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/291764
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 43832
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15291764
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/291764 | Substituted xanthine derivatives | Oct 11, 2016 | Issued |
Array
(
[id] => 11555144
[patent_doc_number] => 20170101390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'METHOD AND APPARATUS FOR PREPARATION OF LACTIDE USING LACTIDE PURIFICATION PROCESS'
[patent_app_type] => utility
[patent_app_number] => 15/290647
[patent_app_country] => US
[patent_app_date] => 2016-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6402
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15290647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/290647 | Method and apparatus for preparation of lactide using lactide purification process | Oct 10, 2016 | Issued |
Array
(
[id] => 12037591
[patent_doc_number] => 09815810
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-11-14
[patent_title] => 'Method of cannabinoid preservation through crystallization and other crystal structures'
[patent_app_type] => utility
[patent_app_number] => 15/287615
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6795
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287615 | Method of cannabinoid preservation through crystallization and other crystal structures | Oct 5, 2016 | Issued |
Array
(
[id] => 13521839
[patent_doc_number] => 20180312462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => BENZAMIDE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 15/763807
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763807
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763807 | Benzamide derivative | Sep 29, 2016 | Issued |
Array
(
[id] => 11532889
[patent_doc_number] => 20170092868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE AND IMAGE SENSOR INCLUDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/272580
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10134
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15272580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/272580 | Compound for organic photoelectric device and organic photoelectric device and image sensor including the same | Sep 21, 2016 | Issued |
Array
(
[id] => 11364014
[patent_doc_number] => 20170001994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'CYCLOPROPANAMINE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/270863
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69613
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15270863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/270863 | Cyclopropanamine compound and use thereof | Sep 19, 2016 | Issued |
Array
(
[id] => 11382808
[patent_doc_number] => 20170008863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'SYNTHESIS OF THERAPEUTIC AND DIAGNOSTIC DRUGS CENTERED ON REGIOSELECTIVE AND STEREOSELECTIVE RING OPENING OF AZIRIDINIUM IONS'
[patent_app_type] => utility
[patent_app_number] => 15/270651
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 66798
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15270651
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/270651 | Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions | Sep 19, 2016 | Issued |
Array
(
[id] => 12099167
[patent_doc_number] => 09856255
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer'
[patent_app_type] => utility
[patent_app_number] => 15/267398
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32061
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15267398
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/267398 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | Sep 15, 2016 | Issued |
Array
(
[id] => 12861964
[patent_doc_number] => 20180179162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => BENZOAZEPINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/759363
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759363
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759363 | Benzoazepine derivatives | Sep 13, 2016 | Issued |
Array
(
[id] => 13386599
[patent_doc_number] => 20180244841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => TRANSFORMATIONS OF MESO-LACTIDE
[patent_app_type] => utility
[patent_app_number] => 15/756670
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756670
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/756670 | Transformation of meso-lactide | Sep 1, 2016 | Issued |
Array
(
[id] => 12347166
[patent_doc_number] => 09951225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Rhodamine derivatives dyes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/252597
[patent_app_country] => US
[patent_app_date] => 2016-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13120
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/252597 | Rhodamine derivatives dyes and uses thereof | Aug 30, 2016 | Issued |